US Stocks
/
Myriad Genetics, Inc. Share Price

Myriad Genetics, Inc. Share Price

NASDAQ: MYGN | Small Cap
$3.25
+$0.07 (2.20%) Last updated on 08 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Myriad Genetics, Inc. Stock Performance

Open
$3.23
Prev. Close
$3.19
Circuit Range
N/A
Day Range
$3.18 - $3.29
Year Range
$2.74 - $8.57
Volume
1,16,534
Average Traded
$3.23

Myriad Genetics, Inc. Share Price Today

As of 10 August 2026, Myriad Genetics, Inc.'s share price is $3.25. The stock opened at $3.23, compared to its previous close of $3.19. During today's trading session, Myriad Genetics, Inc.'s share price traded between $3.18 and $3.29, with an average price of $3.23. Over the past 52 weeks, the stock has recorded a high of $8.57 and a low of $2.74. In terms of performance, Myriad Genetics, Inc.'s share price has declined by 29.55% over the last six months and is down 48.86% on a year-on-year basis.

Myriad Genetics, Inc. Share Price Chart

$3.18$3.29
L
Show Current Price
H

Myriad Genetics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$301.41M
PE Ratio (TTM)
-0.82
Dividend Yield
N/A
EPS (TTM)
$-3.95
Revenue (TTM)
$824.50M
Return On Equity (TTM)
-99.43%
Profit Margin
-44.38%
Debt to Equity
0.36
Quarterly Earnings Growth YoY
-23.98%

Myriad Genetics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
Revenue$202.20M$211.50M$213.30M$195.90M$213.10M$205.70M
Net Profit-$26.00M-$36.70M-$22.10M-$100000.00-$330.50M-$27.40M
Net Profit Margin-12.86%-17.35%-10.36%-0.05%-155.09%-13.32%
Income ChangeN/A-41.15%39.78%99.55%-330400.00%91.71%

Myriad Genetics, Inc. Annual Profit & Loss

All figures in USD

Particulars20212022202320242025
Revenue$690.60M$678.40M$753.20M$837.60M$824.50M
Net Profit-$27.20M-$112.00M-$263.30M-$127.30M-$365.90M
Net Profit Margin-3.94%-16.51%-34.96%-15.20%-44.38%
Income ChangeN/A-311.76%-135.09%51.65%-187.43%

About Myriad Genetics, Inc.

Myriad Genetics, Inc., a molecular diagnostic testing and precision medicine company, develops and provides molecular tests in the United States and internationally. The company offers molecular diagnostic tests for oncology, women's health, and pharmacogenomics. It also provides MyRisk Hereditary Cancer test, a DNA sequencing test for assessing the risks for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic test, a DNA sequencing test to help determine the therapy for metastatic breast, ovarian, metastatic pancreatic, and metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic test, a tumor test that determines homologous recombination deficiency status in patients with ovarian cancer. In addition, the company offers Prolaris Prostate Cancer Prognostic test, an RNA expression tumor analysis for assessing the aggressiveness of prostate cancer; EndoPredict Breast Cancer Prognostic test, an RNA expression test for assessing the aggressiveness of breast cancer; Precise Tumor Molecular Profile test, a genomic profiling test; Prequel Prenatal Screen, a non-invasive prenatal screening test conducted using maternal blood to screen for severe chromosomal disorders in a fetus; Foresight Carrier Screen, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; SneakPeek Early Gender DNA test, a non-invasive blood test that predicts the gender of a fetus; and GeneSight Psychotropic Mental Health Medication test, a DNA genotyping test to aid psychotropic drug selection for depression, anxiety, attention-deficit/hyperactivity disorder, and other mental health conditions. It has a license collaboration with Illumina, Inc.; Memorial Sloan Kettering Cancer Center; the University of Texas MD Anderson Cancer Center; the University of Rochester Medical Center; and Flatiron Health, Inc. The company was founded in 1991 and is headquartered in Salt Lake City, Utah.

Myriad Genetics, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$2.92
$3.25
+13.61%
Jul 2026
$5.78
$2.87
-49.78%
Jun 2026
$4.02
$5.71
+42.63%
May 2026
$4.72
$4.00
-15.61%
Apr 2026
$4.51
$4.74
+5.33%
Mar 2026
$5.08
$4.50
-2.60%
Feb 2026
$5.53
$4.62
-17.79%
Jan 2026
$6.20
$5.62
-8.62%
Dec 2025
$7.49
$6.15
-19.34%
Nov 2025
$8.28
$7.63
-5.03%
Oct 2025
$7.29
$8.03
+11.20%
Sep 2025
$6.42
$7.22
+13.43%

MYGN Share Price FAQs

What is Myriad Genetics, Inc. share price today?

chevron-up
Myriad Genetics, Inc. share price today is $3.25 as on August 8, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Myriad Genetics, Inc. stock?

chevron-up
The 52 week high of Myriad Genetics, Inc. stock is $8.57, while the 52 week low is $2.74 as of 8 Aug '26.

What is MYGN's market capitalisation today?

chevron-up
MYGN market capitalisation is $301.41M as of August 10, 2026, at 12:10 pm IST.

What is MYGN's net income for the last quarter?

chevron-up
MYGN's net income for the last quarter is -0.03B USD.

What is the 5 year returns of MYGN?

chevron-up
The 5 year returns of MYGN is -90.90% as on 8 Aug '26.

What is the high & low stock price of MYGN today?

chevron-up
MYGN stock price hit a high of $3.29 and low of $3.18 as of 8 Aug '26.

Can I buy MYGN shares in India?

chevron-up
Yes. You can buy MYGN in India by opening an international trading account.